These findings indicate that CSF leptin is reduced in AD, correlates closely with plasma leptin, and is linked to brain amyloid pathology, suggesting that plasma leptin may serve as a peripheral indicator of central leptin activity [299]. This evidence concerns the gene LEP and Alzheimer disease.